Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
STAR Protocols|May 15, 2026
Protocol for a multi-modal performance-profiling workflow of CAR T cell productsSarah Schulenberg, Michelle Loeser, Michael Schmueck-Henneresse
Iscience|November 10, 2025
Multi-parametric profiling of IL-7-augmented GD2.CART products in a phase 1 clinical trialSarah Schulenberg, Martí Farrera-Sal, Michelle Loeser, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2025
Effects of CRISPR-Cas9-mediated FOXP3 knockout on CAR T cell potencyLena Peter, Martí Farrera-Sal, Ferhat Ali Yaman, et al.
Molecular Therapy. Nucleic Acids|May 7, 2026
Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporationSamira Picht, Martí Farrera-Sal, Anna L Hiller, et al.
Molecular Therapy. Methods & Clinical Development|March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patientsLena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Science Translational Medicine|January 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancerTino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Biorxiv : the Preprint Server for Biology|December 20, 2023
Integration of ζ-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Blood|March 17, 2024
Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Science Advances|September 4, 2024
Effector memory-type regulatory T cells display phenotypic and functional instabilityDésirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, et al.
Nature Biomedical Engineering|January 21, 2026
Lung tumouroids as a testing platform for precision CAR T cell therapyLukas Ehlen, Martí Farrera-Sal, Martin Szyska, et al.
Pageof 2